Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical Trial

Naoki Iwanaga(Nagasaki University Hospital), Hiroshi Mukae(Nagasaki University), Yurika Kawazoe(Nagasaki University Hospital), Takuto Miyamura(Nagasaki Prefectural Shimabara High School), Yoji Futsuki(Nagasaki Municipal Hospital), Takahiro Takazono(Nagasaki University), Yoshifumi Imamura(Nagasaki University Hospital), Noriho Sakamoto(Nagasaki University), Tomo Mihara(Nagasaki Medical Center), Tsutomu Kobayashi(Kyoto first Red Cross hospital), Shotaro Ide(Nagasaki University Hospital), Satoshi Irifune(Nagasaki Prefectural Shimabara High School), Yusei Tsukamoto(Nishikawa Hospital), Shimpei Morimoto(Nagasaki University), Toru Morikawa(Nagasaki Ajisai Hospital), Yosuke Harada(Nagasaki Ajisai Hospital), Akira Kondo(Nagasaki Medical Center), Yuichi Inoue(Japan Research Institute), Koichi Izumikawa(Nagasaki University), Yohsuke Nagayoshi(Japanese Red Cross Society, Japan), Kiyoyasu Fukushima(Japanese Red Cross Society, Japan), Toyomitsu Sawai(Nagasaki Medical Center), Hiroaki Senju, Naoki Hosogaya(Nagasaki University Hospital), Ryosuke Morio(Japanese Red Cross Society, Japan), Masataka Yoshida(Nagasaki University Hospital), Kazuaki Takeda(Nagasaki University Hospital), Hikaru Tanaka(Sasebo City General Hospital), Kohji Hashiguchi(Japanese Red Cross Society, Japan), Yuichi Fukuda(Sasebo City General Hospital), Naofumi Suyama(Nagasaki Municipal Hospital), Yoshihisa Kohno(Nagasaki Ajisai Hospital), Katsunori Yanagihara(Nagasaki University), Eisuke Sasaki(Nagasaki Medical Center), Yuya Ito(Nagasaki University Hospital)
Cureus
March 11, 2025
Cited by 2


Related Papers